Semaglutide / Cyanocobalamin Injection: 2 recalled over sterility concerns
- Recall date
- August 22, 2024
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- ProRx LLC recalls Semaglutide / Cyanocobalamin Injection: 2.5/0.5 mg/mL, 2 mL Multiple Dose Vial, Compounded Rx Product, ProRX 267-565-70…
- Recall number
- D-0654-2024
- FDA classification
- Class II
- Brand / firm
- ProRx LLC
- Sold / distributed
- Nationwide in the USA
Why it was recalled
Lack of Assurance of Sterility
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Semaglutide / Cyanocobalamin Injection: 2.5/0.5 mg/mL, 2 mL Multiple Dose Vial, Compounded Rx Product, ProRX 267-565-7008, NDC 84139-225-02
Get recall alerts
Free email alert whenever ProRx LLC has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: ProRx LLC